22nd Century Group Initiates Process To Evaluate Strategic Alternatives For Its Tobacco Portfolio
(RTTNews) - Agricultural biotechnology company 22nd Century Group, Inc. (XXII) announced Tuesday that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company's tobacco assets.
The process will include consideration of a range of strategic, operational and financial transactions and alternatives, such as business combinations, asset sales, licensing agreements, alternate financing strategies and other options.
The company said it hopes to identify ways to monetize the value or more effectively expand the market reach of its tobacco portfolio, including its innovative VLN tobacco harm reduction products, the first and only combustible tobacco product to receive a Modified Risk Tobacco Product designation from the U.S. Food and Drug Administration.
The Company has engaged TD Cowen as advisors in its review of strategic alternatives.
22nd Century Group Names Hugh Kinsman As CFO
U.S. Consumer Sentiment Deteriorates More Than Previously Estimated In October
U.S. Consumer Prices Rise 0.3% In September, Slightly Less Than Expected
Eurozone Private Sector Growth At 17-Month High
Bay Street Likely To Open With Positive Bias
U.S. Consumer Prices Rise Slightly Less Than Expected In September
FTSE 100 Retreats After Positive Start
